Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Veterinary Medicine

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1170487

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1170487

Equine Healthcare Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030

PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

Description

Table of Contents

List of Tables

The global equine healthcare market held US$ 626.2 Mn in 2021 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2022 to 2030. Growing trend of horse breeding and horse riding for leisure purpose is the major growth factor of the equine healthcare market. Other factors such as growing incidence of equine infections and development of novel animal safety and health programs will continue to assist the growth of the market. Horse racing for gambling and leisure purpose is highly active in region such as North America, Europe and Asia Pacific which stimulates the demand for equine healthcare products in the region. The companies operating in the market are engaging in research and development of novel products to gain competitive edge in the market.

Drug Segment to Drive the Global Equine Healthcare Market

In 2021, drugs segment held the largest share in the global equine healthcare market owing to growing demand for therapeutic drugs for the treatment of various diseases. Horses are highly prone to diseases such as tetanus, equine encephalomyelitis, rabies, equine influenza, West Nile virus among others which needs to be taken care of. The drugs segment is further segmented in to anti-infective, anti-inflammatory and anti-parasitic drugs. Vaccines held the second largest market is projected to grow at a steady rate during the forecast period. Supplements and additives are expected to exhibit fastest growth rate due to high product launch and growing awareness regarding the benefits of supplements among the equine care takers.

Market is studied in order to understand the current dynamics and future trends in the global equine healthcare market. The study includes market size and forecast for all considered segments presented in the report for the period from 2020 to 2030, along with respective compound annual growth rate (CAGRs) for the forecast period from 2022 to 2030, considering 2021 as the base year. The key players currently engaged in equine healthcare market include Zoetis, Bayer AG, Boehringer Ingelheim (Merial), Vetoquinol S.A., Purina Animal Nutrition LLC, Merck & Co. (Merck Animal Health) among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Equine Healthcare market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Equine Healthcare market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Drug Type
    • Anti-Infective
    • Anti-Inflammatory
    • Parasiticides
    • Others
  • Vaccine Type
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Others
    • Supplements and Additives

Disease

  • West Nile Virus
  • Equine Rabies
  • Potomac Horse Fever
  • Tetanus
  • Equine Influenza
  • Equine Herpes Virus

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Equine Healthcare market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Equine Healthcare market?
  • Which is the largest regional market for Equine Healthcare market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Equine Healthcare market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Equine Healthcare market worldwide?
Show more
Product Code: 138524-08-22

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Equine Healthcare Market
  • 2.2. Global Equine Healthcare Market, By Product, 2021 (US$ Million)
  • 2.3. Global Equine Healthcare Market, By Disease, 2021 (US$ Million)
  • 2.4. Global Equine Healthcare Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Equine Healthcare Market: Competitive Analysis

  • 3.1. Market Positioning of Key Equine Healthcare Market Vendors
  • 3.2. Strategies Adopted by Equine Healthcare Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Equine Healthcare Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Equine Healthcare Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Equine Healthcare Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Drug Type
      • 5.3.1.1. Anti-Infective
      • 5.3.1.2. Anti-Inflammatory
      • 5.3.1.3. Parasiticides
      • 5.3.1.4. Others
    • 5.3.2. Vaccine Type
      • 5.3.2.1. Inactivated
      • 5.3.2.2. Live Attenuated
      • 5.3.2.3. Recombinant
      • 5.3.2.4. Others
    • 5.3.3. Supplements and Additives

6. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. West Nile Virus
    • 6.3.2. Equine Rabies
    • 6.3.3. Potomac Horse Fever
    • 6.3.4. Tetanus
    • 6.3.5. Equine Influenza
    • 6.3.6. Equine Herpes Virus

7. North America Equine Healthcare Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
  • 7.3. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
  • 7.4.Equine Healthcare Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.1.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.2.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.3.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)

8. UK and European Union Equine Healthcare Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
  • 8.3. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
  • 8.4.Equine Healthcare Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.1.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.2.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.3.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.4.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.5.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.6.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)

9. Asia Pacific Equine Healthcare Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
  • 9.3. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
  • 9.4.Equine Healthcare Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.1.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.2.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.3.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.4.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.5.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.6.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)

10. Latin America Equine Healthcare Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
  • 10.3. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
  • 10.4.Equine Healthcare Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.1.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.2.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.3.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)

11. Middle East and Africa Equine Healthcare Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
  • 11.3. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
  • 11.4.Equine Healthcare Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.1.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.2.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Equine Healthcare Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.3.1. Equine Healthcare Market: By Disease, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Bayer AG (Bayer Animal Health)
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Boehringer Ingelheim
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Ceva Sante Animale
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Eli Lilly and Company
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Equine Products U.K. Ltd.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Merck & Co. (Merck Animal Health)
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Purina Animal Nutrition LLC
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Vetoquinol S.A.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Zoetis
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
Show more
Product Code: 138524-08-22

List of Tables

  • TABLE 1 Global Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 3 Global Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 4 Global Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 5 North America Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 6 North America Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 7 North America Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 8 North America Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 9 U.S. Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 10 U.S. Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 11 U.S. Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 12 U.S. Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 13 Canada Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Canada Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 15 Canada Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 16 Canada Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 17 Rest of North America Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Rest of North America Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 19 Rest of North America Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 20 Rest of North America Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 21 UK and European Union Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 22 UK and European Union Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 23 UK and European Union Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 24 UK and European Union Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 25 UK Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 26 UK Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 27 UK Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 28 UK Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 29 Germany Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Germany Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 31 Germany Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 32 Germany Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 33 Spain Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 34 Spain Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 35 Spain Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 36 Spain Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 37 Italy Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Italy Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 39 Italy Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 40 Italy Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 41 France Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 42 France Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 43 France Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 44 France Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 45 Rest of Europe Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 46 Rest of Europe Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 47 Rest of Europe Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 48 Rest of Europe Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 49 Asia Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Asia Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 51 Asia Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 52 Asia Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 53 China Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 54 China Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 55 China Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 56 China Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 57 Japan Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 58 Japan Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 59 Japan Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 60 Japan Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 61 India Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 62 India Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 63 India Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 64 India Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 65 Australia Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 66 Australia Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 67 Australia Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 68 Australia Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 69 South Korea Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 70 South Korea Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 71 South Korea Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 72 South Korea Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 73 Latin America Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 74 Latin America Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 75 Latin America Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 76 Latin America Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 77 Brazil Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 78 Brazil Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 79 Brazil Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 80 Brazil Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 81 Mexico Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 82 Mexico Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 83 Mexico Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 84 Mexico Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 85 Rest of Latin America Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 86 Rest of Latin America Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 87 Rest of Latin America Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 88 Rest of Latin America Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 89 Middle East and Africa Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 90 Middle East and Africa Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 91 Middle East and Africa Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 92 Middle East and Africa Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 93 GCC Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 94 GCC Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 95 GCC Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 96 GCC Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 97 Africa Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 98 Africa Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 99 Africa Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 100 Africa Equine Healthcare Market By Disease, 2020-2030, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Equine Healthcare Market By Product, 2020-2030, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Equine Healthcare Market By Drug Type, 2020-2030, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Equine Healthcare Market By Vaccine Type, 2020-2030, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Equine Healthcare Market By Disease, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Equine Healthcare Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Equine Healthcare Market: Quality Assurance
  • FIG. 5 Global Equine Healthcare Market, By Product, 2021
  • FIG. 6 Global Equine Healthcare Market, By Disease, 2021
  • FIG. 7 Global Equine Healthcare Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Equine Healthcare Market, 2021
  • FIG. 9 Market Positioning of Key Equine Healthcare Market Players, 2021
  • FIG. 10 Global Equine Healthcare Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Equine Healthcare Market, By Product, 2021 Vs 2030, %
  • FIG. 12 Global Equine Healthcare Market, By Disease, 2021 Vs 2030, %
  • FIG. 13 U.S. Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 20 France Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 22 China Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 24 India Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Equine Healthcare Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Equine Healthcare Market (US$ Million), 2020 - 2030
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!